ALOT vs AVGO
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ALOT's Piotroski F-Score of 2/9 indicates severe financial distress, with weak operational and profitability health. The absence of an Altman Z-Score and Graham Number removes critical safety checks, while negative profit margins and declining revenue growth signal deteriorating fundamentals. Despite strong earnings growth (65.1% YoY) and recent EPS surprises, the company's negative ROE (-19.92%) and declining revenue (-3.10% YoY) undermine sustainability. The stock trades at a discount to book value (P/B: 0.86) but lacks intrinsic value support, suggesting the market prices in speculative recovery expectations.
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
Compare Another Pair
Related Comparisons
ALOT vs AVGO: Head-to-Head Comparison
This page compares AstroNova, Inc. (ALOT) and Broadcom Inc. (AVGO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.